# The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab

> **NCT00833729** · PHASE4 · COMPLETED · sponsor: **Dermatrials Research** · enrollment: 10 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** etanercept

## Key facts

- **NCT ID:** NCT00833729
- **Lead sponsor:** Dermatrials Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00833729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00833729, "The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00833729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*